|
PLYX Polaryx Therapeutics, Inc 2075320 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-1,380,000.00 |
| Balance Sheet |
|
Current Assets
|
$11,812,000.00 |
|
Assets
|
$11,812,000.00 |
|
Current Liabilities
|
$873,000.00 |
|
Liabilities
|
$873,000.00 |
|
Equity
|
$10,939,000.00 |
|
Shares Out
|
49845993.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-3,432,000.00 |
| Market Analysis |
Market Cap
|
$106,670,425.02 |
|
Price
|
$2.14 |
|
BVPS
|
0.22 |
|
PB
|
9.73 |
|
EPS
|
-0.03 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:50 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:40 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PLYX documents filed with the SEC.
PLYX Filings
Clear
